EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Development and Statistical Validation of the Metabolic Surgery Indication Score: Standardized Procedure Selection in Metabolic and Bariatric Surgery

Nadia De Falco, Panagiotis Lainas, Yitka Graham, Teresa Nutile, Giuseppe Signoriello, Simone Squillante, Vincenzo Bottino, Sonja Chiappetta

Obesity Facts · 2025

DOI: 10.1159/000548506 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Obesity Facts, 2025. Verfasst von Nadia De Falco und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Laparoscopic Surgery, Bariatric and Metabolic Surgery Unit, Ospedale Evangelico Betania, Naples, Italy. Hauptthemen laut MEDLINE: Bariatric Surgery, Gastrectomy, Obesity, Morbid, Obesity. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sleeve gastrectomy (SG) and one anastomosis gastric bypass (OAGB) are two of the three most performed metabolic and bariatric surgery (MBS) procedures worldwide. Indication for the proper surgical procedure is based on the surgeon’s choice, and no validated score for procedure selection exists. The aim of this study was to develop and validate a clinical score, which standardizes procedure selection in MBS.

Methods

Based on the importance of obesity complications and comorbidities, we created a Metabolic Surgery Indication Score (MetSIS), including ten clinical and laboratory parameters to categorize the complex disease obesity with its comorbidities: age, sex, body mass index (BMI), obstructive sleep apnea syndrome (OSAS), hypertension, dyslipidemia, type 2 diabetes mellitus (T2DM), HbA1c, insulin therapy, and metabolic dysfunction-associated steatotic liver disease (MASLD). Minimum score was 0 points, and maximum 12 points. Retrospectively, data from all patients who underwent primary SG or OAGB in a 4-year period in our center of excellence for MBS were analyzed. Exclusion criteria included reflux disease (esophagitis ≥C next to LA classification) and/or the presence of hiatal hernia (≥3 cm) (since these patients undergo RYGB next to the internal protocol) and revisional bariatric surgery.

Results

From March 2019 to September 2023, 468 patients underwent SG (n = 363) or OAGB (n = 105) as primary bariatric procedure. Mean BMI was 42.1 kg/m2 (SG) and 48 kg/m2 (OAGB). Patients who underwent SG demonstrated lower MetSIS, while patients who underwent OAGB had a higher score (p < 0.001). The parameters BMI (p < 0.001), presence of OSAS associated with CPAP treatment (p < 0.001), hypertension (p < 0.001), T2DM (p < 0.001), insulin requirement (p = 0.001), and MASLD (p = 0.035) were found as statistically significant parameters which influenced procedure choice.

Conclusion

The MetSIS is a simple and immediate score, which can be applied during decision-making of MBS procedure in routine clinical settings. Further studies are necessary to associate this score to the real metabolic outcome during long-term follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bariatric SurgeryGastrectomyObesity, MorbidObesityGastric BypassHumansMaleFemaleMiddle AgedRetrospective StudiesAdultBody Mass IndexDiabetes Mellitus, Type 2Patient SelectionSleep Apnea, ObstructiveComorbidity

Stichwörter der Autor:innen

Bariatric and metabolic procedure selectionMetabolic surgeryOne anastomosis gastric bypassPrimary bariatric procedureProcedure selectionSleeve gastrectomy

Autor:innen und Institutionen

  • Department of General and Laparoscopic Surgery, Bariatric and Metabolic Surgery Unit, Ospedale Evangelico Betania, Naples, Italy.
  • Department of Metabolic and Bariatric Surgery, Metropolitan Hospital, Athens, Greece, drlainas@gmail.com.
  • Division of Surgery, School of Medicine, European University of Cyprus, Nicosia, Cyprus, drlainas@gmail.com.
  • Helen McArdle Nursing and Care Research Institute, University of Sunderland, Sunderland, UK.
  • Department of General Surgery, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
  • Institute of Genetics and Biophysics "A. Buzzati-Traverso", CNR, Naples, Italy.

Zitieren

APA

De Falco, N., Lainas, P., Graham, Y., Nutile, T., Signoriello, G., Squillante, S., Bottino, V., & Chiappetta, S. (2025). Development and Statistical Validation of the Metabolic Surgery Indication Score: Standardized Procedure Selection in Metabolic and Bariatric Surgery. Obesity Facts. https://doi.org/10.1159/000548506

Vancouver

De Falco N, Lainas P, Graham Y, Nutile T, Signoriello G, Squillante S, et al. Development and Statistical Validation of the Metabolic Surgery Indication Score: Standardized Procedure Selection in Metabolic and Bariatric Surgery. Obesity Facts. 2025. doi:10.1159/000548506

BibTeX
@article{DeFalco2025,
  author = {De Falco, Nadia and Lainas, Panagiotis and Graham, Yitka and Nutile, Teresa and Signoriello, Giuseppe and Squillante, Simone and Bottino, Vincenzo and Chiappetta, Sonja},
  title = {Development and Statistical Validation of the Metabolic Surgery Indication Score: Standardized Procedure Selection in Metabolic and Bariatric Surgery},
  journal = {Obesity Facts},
  year = {2025},
  doi = {10.1159/000548506}
}
Kostenlos starten →